)
Visual21 Nov 2025
Data center suppliers
Pharming Group (PHARM) investor relations material
Pharming Group Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Jefferies London Healthcare Conference 2025 summary19 Nov, 2025
Company evolution and strategic focus
Transitioned from a single-asset pharma to a high-growth biotech with two marketed assets and a robust pipeline, each with $1 billion revenue potential.
CEO joined to unlock value and apply a 10x growth mindset.
Focused on disciplined capital allocation, recently cutting 20% of G&A headcount to redirect resources to growth areas.
Attracted a new CFO with a strong value creation background to optimize P&L management.
RUCONEST performance and market strategy
RUCONEST continues double-digit growth, serving severe HAE patients not controlled by other treatments.
Maintains a unique position due to its efficacy, fast onset, and IV administration for hard-to-treat cases.
U.S. market remains the primary revenue source; exited non-U.S. markets due to low sales and high administrative burden.
Focus is on sustaining growth and reinvesting proceeds into high-growth assets.
Joenja growth opportunities and expansion
Joenja, for APDS, is in early high-growth phase with accelerating patient uptake.
Pediatric label expansion expected by end of January, potentially increasing addressable market by 30%.
Reclassification of VUS patients could boost APDS market by 50%, with process underway following new scientific data.
Ongoing trials in adjacent immunodeficiencies with much larger prevalence, with readouts expected in H2 2026.
Successful U.K. launch; EMA and Japan approvals targeted for next year as part of a focused international expansion.
Joenja VUS reclassification timeline?
KL1333 commercialization synergies?
Capital allocation strategy for growth?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Pharming Group earnings date
Q4 20252 Apr, 2026
Next Pharming Group earnings date
Q4 20252 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Pharming Group N.V. is a global biopharmaceutical company based in Leiden, the Netherlands. The company specializes in the development and commercialization of protein replacement therapies and precision medicines, particularly for rare diseases. Pharming's key product is RUCONEST, a plasma-free recombinant human C1 esterase inhibitor used for treating acute hereditary angioedema (HAE). The company also has several other products in various stages of development, including treatments for Pompe and Fabry diseases and other rare disorders. The company is headquartered in Leiden, the Netherlands, and its shares are listed on both the Amsterdam Euronext and Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage